Delivery Order SPE2DR25D1100-SPE2DR26FCW7F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 30, 2025. This firm fixed-price delivery order, valued at $7,797.84, represents a single-unit procurement from AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with completion scheduled for December 31, 2025. No...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with a ceiling value of $16,289.67 under firm fixed-price terms. The contract is set to be completed by August 6, 2025, with the place of performance located in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,622.22 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed price, non-set-aside competitive award with a completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors, with a ceiling value of $46,729.78 under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,358.72 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,157.68 on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive, firm fixed-price delivery order is set to be completed by December 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,435.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order represents a non-competitive award issued under DLA's existing contract vehicle with the pharmaceutical distributor. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,511.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on December 15, 2025, with a completion date of December 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under DLA's broader pharmaceutical supply framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $5,646.62. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement under open competition. The contract has an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors with a firm fixed price of $12,222.69 and completion deadline of September 23, 2025. This non-competitive delivery order represents a single-unit transaction executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCW7FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,192.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 29, 2025, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The supply of Zepbound, a diabetes medication, reflects AmerisourceBergen's role as a critical vendor for federal medical procurement supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.2k | 12/28/25 |